knowledge -WSS

knowledge

author：explore 2025-08-23 05:02:07 - browse：38

The back of three medicine containers, a bottle in between two boxes, all showing labels — coverage from STAT — Adobe

After a drug enters the market, it’s up to Food and Drug Administration regulators to ensure its continued safety and efficacy. A recent New York Times story suggests that, in the case of the popular asthma drug Singulair, the FDA fell short — both because the agency delayed action for years on reports from patient advocates and independent groups that the drug could cause suicidal thoughts, and because when it did add a warning label about its potential side effects in 2020, clinicians and patients still weren’t always aware of the risks.

Experts say that the Singulair incident highlights a flawed system, both in the U.S. and globally, for monitoring adverse reactions after a drug is on the market — one that will require extensive changes to address.

“The question is, how safe do you want to be?” said Ameet Sarpatwari, the assistant director of the Program on Regulation, Therapeutics, and Law at Brigham and Women’s Hospital. Ideally, he said, the FDA should be able to both stay on top of safety concerns and avoid unnecessarily restricting access to drugs. “Are we at the right balance? I think there are definitely situations for many drugs where you can say, no, we’re not really at the right balance, and the FDA should be taking a more aggressive stance in promoting patient safety.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Community addresses injustice for Long Island mothers

hotspot

WSS

PhRMA sues HHS over Medicare drug price negotiation

Trans patients at the end of life deserve respect and dignity

Vivek Ramaswamy made waves in the debate, much as in biotech

Connecting traumatic brain injury and domestic violence

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

Abortion policy in the spotlight at Republican debate

entertainment

knowledge

hotspot

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Doctor appointment wait times are getting worse

ChatGPT in medicine: STAT answers readers' burning questions

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

ChatGPT in medicine: STAT answers readers' burning questions

Former Pear Therapeutics executives start new VC firm

In Memoriam: Notable people who died in 2023

How the drug

Jerome Adams on the need for new antivirals for Covid

How the drug

entertainment

National associations that represent hospice owe an apology

Listen: Vivek Ramaswamy's star turn & leaky drug data

Australia's humpback populations rebound raising hopes of marine scientists

Why is France rioting? What to know about the fatal police shooting of Nahel M

Kellogg’s is going to war over Mexico’s nutrition label rules

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

hotspot

focus

hotspot

focus